researchmmm acquir wound solut provid acel bil largest acquisit histori sentiment indic neutral presenc advanc surgic wound care solut billion purchas acel may outperform-r announc acquir acel kci subsidiari privat equiti sponsor includ apax partner total enterpris valu billion repres largest deal-siz histori second major acquisit spearhead ceo mike roman follow billion modal deal previous commun advanc wound care area strateg focu surpris see invest impli deal multipl trail ebitda sale look reason view uniqu med-tech asset lead market posit ebitda margin mid-single-digit organ growth trajectori estim acel would increas size revenu roughli account segment mix importantli target high-single-digit year-fiv impli compromis return benchmark deal valuat like see compani becom comfort aggress large-scal previous dip toe multi-billion dollar deal capit safeti billion scott safeti billion recal histor eschew larg acquisit given prior prefer homegrown d-driven growth one modest disappoint deal announc dial back share buy-back plan accommod purchas acel buy-back target cut billion billion believ investor like see certainti share buyback trim given stock sell-off past week said stock reaction may rel contain view consid acquir deal magnitud reduct share buyback base rough math adjust ep accret would addit ep estim though deal dilut basi transact detail lpurchas price acquir acel roughli billion includ assumpt debt deal financ mixtur cash hand billion quarter-end new debt issuanc ltransact multipl acel revenu billion adjust ebitda million deal valuat impli multipl price/sal trail ebitda note multi-industri sector averag ev/ebitda current roughli impli transact multipl reason view addit estim deal valuat roughli forward-year ebitda includ year-thre run-rat cost synergi exclud synergi estim forward-year ebitda multipl would roughli lsynergi target year-thre run-rat cost synergi acel revenu roughli million level cost synergi roughli in-lin multi-industri sector averag deal estim driver synergi includ organiz cost save sourc sale market integr furthermor revenu synergi bake manag assumpt would addit deal accret target lrevenu overlap reportedli neglig confer call dismiss current meaning revenu overlap acel lep accret basi manag estim acel deal dilut ep first month includ potenti financ cost howev exclud purchas account one-tim integr cost deal would accret period lcomplet date acquisit expect close subject regulatori approv target mid-single-digit organ growth acel roughli in-lin billion address market acel gener billion revenu compris neg pressur wound therapi advanc wound dress specialti surgic product geograph mix roughli america addit busi achiev organ revenu growth outpac address market specif manag estim advanc wound care market billion size grow annual driven rise rate chronic health condit global demograph chang look ahead conserv assum acel organ revenu grow in-lin market mid-single-digit pace manag busi outgrowth share gain addit although acel histor trend revenu expect dial futur innov spend busi given run nearli revenu identifi advanc wound care one prioriti growth platform overview acel roughli revenu america acel lead medic technolog compani focus advanc wound care specialti surgic applic compani offer comprehens suit product use across clinic applic care set clinician group speed soft tissu heal improv clinic outcom decreas overal cost care offer rang complementari solut often use togeth sequenc across multipl care set acel abl address patientsne throughout heal process offer healthcar provid singl sourc address need busi compris three main product line lneg pressur wound therapi npwt sale npwt product line consist therapi devic advanc technolog dress patient suffer acut chronic wound therapi acceler wound heal process reduc heal time flagship npwt devic includ ulta therapi activ therapi npwt gener billion revenu repres acel total mix y/i growth manag believ global market npwt roughli billion size ladvanc wound dress awd awd product line entail wide-rang portfolio dress across mani categori includ collagen super-absorb foam gell fiber contact layer acel awd product line help manag acut chronic wound across care continuum often use npwt specialti surgic product awd gener million revenu repres acel total mix growth y/i manag believ global awd market size lspecialti surgic specialti surgic product line consist numer product market prevena abthera brand acut care set leverag expertis neg pressur technolog compani launch new offer specialti surgic applic design specif surgic suit prevena product employ neg pressur manag close surgic incis protect incis extern contamin also remov fluid infecti materi abthera temporari abdomin closur system use manag patient open abdomen specialti surgic product line gener million revenu repres acel total mix growth y/i manag size global address market specialti surgic product plan platform extens billion acel compani overview sourc compani report compani nameexchangetickerratingrisk qualifierpric targetcurrencypricepric companynysemmm usoutperformnot may et capit market llc dean dray capit market llc andrew krill david lu jeffrey reiv senior click conflict interest disclosur relat compani dean dray disclosur also avail send written request capit market research publish bay street royal bank plaza floor south tower toronto ontario email right reserv materi may publish broadcast rewritten redistribut form pleas click legal restrict term use applic site use site signifi agreement term use
